Leprosy (Hansen’s Disease)
Leprosy is a chronic granulomatous bacterial infection caused by the bacillus Mycobacterium leprae (M.leprae) that primarily affects the skin and peripheral nerves. Leprosy is a multi-organ infectious disease that can cause severe disability. Lepromatous leprosy is considered to be at the systemic and infectious end of the disease spectrum and correlates with an absence of an immune response to M. leprae antigens. Tuberculoid leprosy form correlates with adequate immune response, lesions are not usually large or numerous and it may resolve spontaneously. Multidrug therapy treatment is a highly effective cure for leprosy. Leprosy may be complicated by episodes of immunological instability including type-1 and type-2 reactions (erythema nodosum leprosum).
KeywordsLeprosy Hansen’s disease Mycobacterium leprae Multidrug therapy Erythema nodosum leprosum
- Hansen GHA. Undersøgelser Angående Spedalskhedens Årsager (investigations concerning the etiology of leprosy). Norsk Mag Laegervidenskaben. 1874;4:1–88.Google Scholar
- National Leprosy Elimination Program (NLEP) India. Modified guidelines on MDT regimens to be followed under NLEP. New Delhi: Leprosy Division, Directorate General of Health Services, Ministry of Health and Family Welfare; 1997.Google Scholar
- WHO. Global leprosy situation. Wkly Epidemiol Rec. 2012;87:317–28.Google Scholar
- WHO MDT: duration of treatment. http://www.who.int/lep/mdt/duration/en/index1.html. Accessed 1 Apr 2014.
- WHO recommended MDT regimens. http://www.who.int/lep/mdt/regimens/en/. Accessed 1 Apr 2014.
- WHO. Chemotherapy of leprosy. http://www.who.int/lep/resources/Chemotherapy.pdf?ua=1. Accessed 1 Apr 2014.
- WHO. Leprosy today. http://www.who.int/mediacentre/factsheets/fs101/en/. Accessed 1 Apr 2014.